Read More Pharma Industry News Datopotamab deruxtecan shows promise in Phase III trial for NSCLC AstraZeneca and Daiichi Sankyo have announced promising results from the TROPION-Lung01 Phase III trial, highlighting datopotamab deruxtecan’s potential… byPallavi MadhirajuMay 28, 2024